Exosome Research Market to be Led by Kits and Reagents Through 2028
Advancements in exosome isolation and analysis are
expected to drive the global exosome research market during the forecast
period.
According to the TechSci Research report, “Exosome
Research Market - Global Industry Size, Share, Trends, Opportunities, and
Forecast, 2018-2028,” the exosome research market worldwide is anticipated
to grow at an impressive rate in the forecast period. This can be
ascribed to the growing technological advancements in exosome isolation and
analytical procedures, growth in government and non-government initiatives for
exosome research, and the increasing prevalence of cancer across the world.
Additionally, the growing need for the identification
of cancer biomarkers, detection of infectious agents, and discovery of
treatment options for neurodegenerative & cardiovascular diseases (CVDs)
are the major factors driving the growth of the market during the forecast
period. Also, the rising demand for fast, accurate, and minimally invasive
diagnostic procedures, thus, represents a promising opportunity for the growth
of exosome applications, which will further boost the global exosome research
market during the forecast period.
Besides, increased research programs concentrating on
ascertaining the importance of exosomes in hepatocellular carcinoma (HCC) are
driving the demand for the exosome research market during the forecast period.
However, there is currently a lack of standardized protocols for exosome
isolation, analysis, and characterization, which can make it difficult for
researchers to compare and replicate findings across studies, which can slow
down the growth of the market during the forecast period. Also, the regulatory
environment for exosome-based products and services is complex and evolving
which may restrict the growth of the global exosome research market. Similarly,
the current methods for exosome isolation and analysis can be time-consuming
and costly which may hamper the growth of the market during the forecast
period.
Browse over XX market data figures spread through xx
pages and an in-depth TOC on the “Global Exosome Research Market.”
The exosome research market can be segmented by
product, indication, application, and region.
Based on the product, the global market can be
segmented into kits and reagents, instruments, and other products. The kits and
reagents segment dominated the market in 2022 and is expected to continue
maintaining its dominance throughout the forecast period. This can be
attributed to the increase in the need for molecular diagnosis and the surge in
R&D activities for diagnosis due to advancements in R&D activities in
the healthcare sector and an increase in the number of key manufacturers.
Based on application, the market can be grouped into
biomarkers, vaccine development, tissue regeneration, and other applications.
The biomarkers segment is expected to dominate during the forecast period on
account of the growing demand for the treatment of different cancers, such as
melanoma patients, and the increasing incidence of neurodegenerative disease. Also,
growing research and development activities for novel drugs for the treatment
of chronic diseases are expected to create lucrative growth opportunities
during the forecast period.
Major companies operating in the global exosome
research market are:
- Thermo Fisher Scientific
- System Biosciences
- Bio-Techne
- Lonza
- QIAGEN
- ExoDx
- Hitachi Chemical
- Aethlon Medical
- NanoSomiX
- Malvern Panalytical
- Sistemic Scotland Limited
- NX PharmaGen
July 2022: Cells for Cells, a clinical-stage biotech pioneering
allogeneic stem cell and stem-cell-derived therapeutics for high-impact chronic
diseases, announced a 6-month follow-up of the groundbreaking clinical data
from the first-ever patient dosed with an exosome-produced therapy for
osteoarthritis.
April 2022: Global Stem Cells Group (GSCG) announced the launch
of its new product with new lyophilized exosome technology. Global Stem Cells
Group's new product line includes innovative anti-aging products that can
regenerate cells and tissues in the body.
November 2021: Lonza, a global manufacturing
partner to the pharma, biotech, and nutrition industries, announced the
acquisition of an exosome manufacturing facility in Lexington, Massachusetts
(US) from Codiak BioSciences, a clinical-stage biopharmaceutical company
pioneering the development of exosome-based therapeutics.
Download Free Sample Report
Customers can also request 10% free
customization on this report.
“North America is expected to dominate the global
exosome research market during the forecast period on account of the improved
healthcare facilities, efficacious government initiatives, a large foundation
of multi-national corporations, and increased public consciousness concerning
diagnostics and medicare. Similarly, A huge proportion of government-funded
scientific analyses have been performed on the vocation of drugs containing
exosomes in various types of cancers, including melanoma, breast cancer, lung
cancer, and pancreatic cancer, among many that are expected to create lucrative
growth in the market during the forecast period. Also, the increasing wide
uptake of emerging micro-nanotechnologies for extracellular vesicles in
immuno-oncology ranging from target-specific isolations to immunomodulation is
expected to drive the growth of the market during the forecast period.
Furthermore, a surge in government-funded research
studies, conducted regarding the role of drugs using exosomes in several types
of cancer, such as melanoma, breast cancer, lung cancer, and pancreatic cancer,
will further be expected to create lucrative opportunities for market growth,”
said Mr. Karan Chechi, Research Director at TechSci Research, a research-based
global management consulting firm.
Exosome Research Market - Global
Industry Size, Share, Trends, Opportunities, and Forecast, 2018-2028, Segmented
by Product (Kits and Reagents, Instruments, and Other Products), By Indication
(Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious
diseases, and Others), By Application (Biomarkers, Vaccine Development, Tissue
Regeneration, and Other Applications), By Region and Competition has
evaluated the future growth potential of global exosome research market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision-makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in the global exosome research market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com